Yunhu Health Completed 220 Million Yuan Pre-B Round of Financing Led by ZWC Ventures, To Accelerate the Layout of Basic Medical Industry

According to VCBeat, Yunhu Health announced that it had completed 220 million yuan in the Pre-B round of financing to “Find Health”, its Internet service platform of the basic medical industry. This round of financing is led by ZWC Ventures, with support from existing investors including China Creation Ventures (CCV), BioTrack Capital and CASH Capital.

Yunhu Health is a Chinese third-party medical testing service platform for the grassroots medical system. It mainly sends the inspection samples to the laboratory through the self-built cold chain logistics transportation system. After testing, analysis, and review, the test results will be uploaded to the cloud call inspection service cloud platform. Customers can log on to the platform to download and view. 

The platform also provides accurate inspection services, health management services and value-added services such as inspection report interpretation and disease diagnosis and treatment recommendations to help improve the comprehensive diagnosis and treatment capabilities of primary medical institutions. 

Since its establishment in January 2017, Yunhu Health has built “Find Health” under the direction of graded diagnosis and treatment policy to break through the situation of “industrial information island”. Through the SaaS platform system software and grassroots medical check-ups services, Yunhu Health occupies 15% of the primary care market and has rapidly developed into a leading company providing superposition drugs, devices, psychiatry, and other diversified products and services. "Find Health" platform has formed a strong brand influence in the industrial chain.

Yunhu Health will mainly use this round of financing in the following aspects:

1. To further develop the " Find Health" platform for grassroots customers with the complement of medical devices and other products, expand the service boundaries, transfer itself from the primary inspection solution provider to the basic medical solution provider.

2. To further strengthen professional education and the transformation of customers.

3. To increase research and development investment, strengthen the construction of technology medium, focus on the development of information product matrix, and get through the whole industrial process of grassroots medical industry service.

4. To improve the infrastructure construction of the supply system and the logistics warehouse.

5. To build a more professional and powerful grassroots medical service team.

ZWC Ventures(ZWC) is a USD fund focused on early-to-mid stage investments, providing startup companies with capital and value-added services. It focuses primarily on the TMT and consumer sectors, with strong resources and experience in media, internet, fashion, retail, etc. Specific investment themes include new technologies, consumer spending upgrades, artificial intelligence, as well as the digitalization of media and consumer spending habits. The fund mainly invests during the Seed, Series A, and B stages.

Founded in 2017, BioTrack Capital is a dedicated healthcare fund focused on building and incubating innovative life science companies in China. It manages both RMB and USD funds. The company continually seeks out and looks to discover innovative biotech companies, innovative med-tech companies, and innovative business models in healthcare with outstanding entrepreneurs.

CCV was founded by the former KPCB China Managing Partner, Wei Zhou, and his TMT investment team of many years in KPCB China. With the majority of members from KPCB China, CCV has developed deep domain expertise and insight in the TMT industry. The companies they invested at early stage include JD.com, CreditEase, Rong360, etc. Many of the CCV’s portfolio have seen significant business growth and closed a new round of financing.

CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.